BridgeBio Pharma, Inc. (BBIO)
74.29
+0.02
(+0.03%)
USD |
NASDAQ |
Nov 06, 16:00
74.40
+0.11
(+0.15%)
After-Hours: 20:00
BridgeBio Pharma Total Long Term Debt (Quarterly) : 3.376B for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 3.376B |
| June 30, 2026 | 3.370B |
| March 31, 2026 | 3.359B |
| December 31, 2025 | 2.711B |
| September 30, 2025 | 2.691B |
| June 30, 2025 | 2.668B |
| March 31, 2025 | 2.350B |
| December 31, 2024 | 2.205B |
| September 30, 2024 | 1.725B |
| June 30, 2024 | 1.725B |
| March 31, 2024 | 1.724B |
| December 31, 2023 | 1.736B |
| September 30, 2023 | 1.731B |
| June 30, 2023 | 1.730B |
| March 31, 2023 | 1.725B |
| December 31, 2022 | 1.720B |
| September 30, 2022 | 1.712B |
| June 30, 2022 | 1.707B |
| Date | Value |
|---|---|
| March 31, 2022 | 1.724B |
| December 31, 2021 | 1.723B |
| September 30, 2021 | 1.396B |
| June 30, 2021 | 1.394B |
| March 31, 2021 | 1.379B |
| December 31, 2020 | 490.53M |
| September 30, 2020 | 480.13M |
| June 30, 2020 | 475.68M |
| March 31, 2020 | 470.02M |
| December 31, 2019 | 91.79M |
| September 30, 2019 | 75.02M |
| June 30, 2019 | 554.04M |
| March 31, 2019 | 533.90M |
| December 31, 2018 | 533.37M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.951B |
| Ionis Pharmaceuticals, Inc. | 2.189B |
| Pfizer Inc. | 62.60B |
| Cytokinetics, Inc. | 1.251B |
| Vertex Pharmaceuticals, Inc. | 5.479B |